University of Arkansas scientists study soybean cyst nematode proteins to develop gene-edited soybean varieties resistant to ...

A panel session at Eurosatory 2026 brought together industry, academia and the French armed forces to assess how Ukraine’s ...

Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

A common probiotic bacterium, Bifidobacterium animalis, secretes mannose—a simple sugar—that significantly suppresses melanoma growth in mice by ...

Agricultural scientists are rethinking their battle plans against plant parasites that cause billions of dollars in annual ...

BiTAC® is a registered trademark of VERAXA Biotech GmbH.

Approval of pediatric strategy validates clinical data package and accelerates the regulatory path for CORDStrom™ in the United KingdomBOCA ...

Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ...

Researchers at Karolinska Institutet have uncovered how serotonin-related metabolism helps regulate an understudied immune ...

Araris Biotech AG, a company advancing a differentiated pipeline of antibody-drug conjugates (“ADCs”) therapies, and Taiho Oncology, Inc., a company developing and commercializing novel treatments for ...

Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that ...